Document Detail


Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo?
MedLine Citation:
PMID:  2547379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The possibility of changing the tissue content of kynurenic acid (KYNA), a tryptophan metabolite which acts as an antagonist of the excitatory amino acid receptors, was investigated by measuring its concentration in the brain, blood, liver and kidney of rats using a specific method based on ion exchange chromatography and HPLC. The administration of tryptophan (TRP) or of its keto analogue, indolpyruvic acid (IPA) (50-500 mg/kg i.p.), significantly increased, in a dose-dependent manner, the content of KYNA in various organs, including the brain. The increased brain content of KYNA after IPA administration could not be completely explained by considering that IPA may be transaminated to TRP and that the enzymes leading from TRP to KYNA are known. An alternative pathway of KYNA synthesis from IPA was therefore proposed. These findings indicate that it is possible to change the brain content of an endogenous glutamate antagonist. This could be a new avenue to modulate in vivo excitatory amino acid receptors.
Authors:
P Russi; V Carlà; F Moroni
Related Documents :
423709 - Lipogenesis in the developing brain: utilization of radioactive leucine, isoleucine, oc...
6133219 - Genetic dissection of monoamine neurotransmitter synthesis in drosophila.
11400909 - Brain fatty acids in perinatal asphyxia.
3372639 - Analysis of amino acids in brain and plasma samples by sensitive gas chromatography-mas...
16824509 - Changes in brain interleukin-1beta following the coadministration of norfloxacin with b...
8272269 - Uridine diphosphate-glucuronosyltransferase activities in rat brain microsomes.
18964099 - A new method for the atomic-absorption determination of lead blended as lead alkyls in ...
10980499 - Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emu...
7827069 - Immunosuppressive activity of chemically synthesized gangliosides.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochemical pharmacology     Volume:  38     ISSN:  0006-2952     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  1989 Aug 
Date Detail:
Created Date:  1989-08-28     Completed Date:  1989-08-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  2405-9     Citation Subset:  IM    
Affiliation:
Department of Preclinical and Clinical Pharmacology, Firenze, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain / metabolism*
Indoles / physiology*
Kidney / metabolism
Kynurenic Acid / metabolism*
Liver / metabolism
Male
Myocardium / metabolism
Probenecid / pharmacology
Rats
Rats, Inbred Strains
Receptors, Amino Acid
Receptors, Cell Surface / metabolism
Tryptophan / physiology*
Chemical
Reg. No./Substance:
0/Indoles; 0/Receptors, Amino Acid; 0/Receptors, Cell Surface; 392-12-1/indol-3-yl pyruvic acid; 492-27-3/Kynurenic Acid; 57-66-9/Probenecid; 73-22-3/Tryptophan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bluetongue virus-17 fusion protein ns1 expressed in Escherichia coli by pUC vectors.
Next Document:  Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibi...